None listed
Conditions
Brief summary
Detrusor overactivity with detrusor underactivity (DO-DU) is classically described in frail institutionalized elderly patients, but we have also observed this diagnosis in younger populations. This research attempts to retrospectively compare demographic characteristics, clinical presentations, and urodynamic findings between two age groups of DO-DU patients: those younger than 70 years and those aged 70 years or older. Our hypothesis predicts that the younger group would exhibit a higher prevalence of risk factors in their demographic data, while the elderly group will demonstrate a greater incidence of urgency and urge incontinence, likely attributed to limited mobility. Additionally, the urodynamic findings are expected to reveal less bladder contraction in the elderly group, which can be attributed to the effects of advanced age.
Interventions
This research retrospectively attempts to compare demographic characteristics, clinical presentations, and urodynamic findings between two age groups of detrusor overactivity with detrusor underactivity (DO-DU) patients: those younger than 70 years and those aged 70 years or older. This research is collecting data using a retrospective approach from medical records, absent any direct patient involvement. An approximate total of 250 patients diagnosed with DO-DU, who underwent multichannel urodynamic testing at a single center from 2012 to 2023, were included in this study. Patients were divided into two groups: the “Younger” group (aged less than 70 years) and the “Older” group (aged 70 years or older). We compared demographics, number of risk factors considered to affect bladder function, clinical presentations, and urodynamic findings between these two groups using univariate statistical analysis.
Sponsors
Eligibility
Inclusion criteria
1. Over the age of 18 years underwent urodynamic study between 2012 and 2022. 2. Patient diagnosed with DO-DU from urodynamic study.
Exclusion criteria
1. A lack data for analysis. 2. Patients who have undergone intravesical botulinum toxin injections within the preceding 9 months.